Jane Street Group, LLC Biom X Inc. Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.05 - $0.7 $1,865 - $26,114	37,306 Added 166.08%	59,768 $20,000
Q2 2022 Aug 16, 2022	SELL	N/A	-2,522 Reduced 10.09%	22,462 $16,000
Q1 2022 May 17, 2022	BUY	N/A	24,984 New	24,984 $48,000
Q4 2021 Feb 15, 2022	SELL	N/A	-43,894 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	N/A	43,894 New	43,894 $134,000

Q2 2021 Aug 16, 2021	SELL	N/A	-25,365 Closed	0 $0
Q1 2021 May 18, 2021	BUY	N/A	25,365 New	25,365 $181,000
Q3 2020 Nov 17, 2020	SELL	N/A	-17,424 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	N/A	17,424 New	17,424 $96,000

13.8M

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $10.2M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.